Also trades as: SKSUY (OTC) · $vol 0M
4204.T JPX
Sekisui Chemical Co., Ltd.
1W: +0.6%
1M: -5.9%
3M: -3.6%
YTD: -15.3%
1Y: -7.1%
3Y: +33.5%
5Y: +50.1%
¥2,499.00 ($15.83)
-36.00 (-1.42%)
Weekly Expected Move ±2.5%
¥2374
¥2437
¥2499
¥2561
¥2624
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$1.31T
+0.9% ▲
5Y CAGR: +4.4%
Gross Profit
$424.2B
+5.0% ▲
5Y CAGR: +5.1%
Operating Income
$106.5B
-1.4% ▼
5Y CAGR: +9.6%
Net Income
$75.2B
-8.2% ▼
5Y CAGR: +12.6%
EPS (Diluted)
$182.70
-6.8% ▼
5Y CAGR: +14.7%
EBITDA
$164.6B
-5.8% ▼
5Y CAGR: +7.7%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $1.16T | $1.24T | $1.26T | $1.30T | $1.31T |
| YoY Growth | +9.6% | +7.3% | +1.1% | +3.3% | +0.9% |
| Cost of Revenue | $802.0B | $865.3B | $864.3B | $893.6B | $885.1B |
| Gross Profit | $356.0B | $377.2B | $392.2B | $404.1B | $424.2B |
| Gross Margin | 30.7% | 30.4% | 31.2% | 31.1% | 32.4% |
| R&D Expenses | $37.0B | $40.5B | $41.7B | $44.2B | $0 |
| SG&A Expenses | $215.9B | $230.2B | $297.8B | $251.9B | $317.7B |
| Operating Expenses | $267.1B | $285.6B | $297.8B | $296.2B | $317.7B |
| Operating Income | $88.9B | $91.7B | $94.4B | $108.0B | $106.5B |
| Operating Margin | 7.7% | 7.4% | 7.5% | 8.3% | 8.1% |
| Interest Expense | $774M | $871M | $1.1B | $1.0B | $1.4B |
| Income Before Tax | $69.9B | $99.5B | $111.5B | $120.0B | $105.0B |
| Tax Expense | $31.1B | $28.7B | $32.4B | $35.9B | $27.7B |
| Net Income | $37.1B | $69.3B | $77.9B | $81.9B | $75.2B |
| Net Margin | 3.2% | 5.6% | 6.2% | 6.3% | 5.7% |
| EPS (Diluted) | $83.17 | $159.19 | $183.48 | $195.93 | $182.70 |
| EBITDA | $119.3B | $150.8B | $165.3B | $161.7B | $164.6B |
| Shares Outstanding | 446M | 435M | 425M | 418M | 411M |